Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine L M Lamfers

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Opinion in Molecular Therapeutics|October 8, 2004
Multicellular tumor spheroids in gene therapy and oncolytic virus therapyMartine L M Lamfers, Akseli Hemminki
Handbook of Clinical Neurology|November 8, 2017
Cerebrospinal fluid biomarkers of malignancies located in the central nervous systemCassandra Verheul, Anne Kleijn, Martine L M Lamfers
Cancers|February 15, 2022
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase InhibitorsFederica Fabro, Martine L M Lamfers, Sieger Leenstra
Viruses|August 28, 2021
The Multifaceted Role of Macrophages in Oncolytic VirotherapyLaura Hofman, Sean E Lawler, Martine L M Lamfers
Cancers|February 9, 2021
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for ResponseEftychia Stavrakaki, Clemens M F Dirven, Martine L M Lamfers
Cell Death & Disease|October 7, 2025
Cut the fat: targeting cholesterol and lipid metabolism in glioblastomaSafet Zekanovic, Puspha Achaiber Sing, Sieger Leenstra, et al.
CNS Oncology|March 18, 2016
Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastomaSubramanian Venkatesan, Martine L M Lamfers, Clemens M F Dirven, et al.
Cancers|August 12, 2022
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Sieger Leenstra, et al.
Human Gene Therapy|August 22, 2014
Changing faces in virology: the dutch shift from oncogenic to oncolytic virusesZineb Belcaid, Martine L M Lamfers, Victor W van Beusechem, et al.
Current Cancer Drug Targets|August 17, 2016
Malignant Glioma In Vitro Models: On the Utilization of Stem-like CellsRutger K Balvers, Clemens M F Dirven, Sieger Leenstra, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Opinion in Molecular Therapeutics|October 8, 2004
Multicellular tumor spheroids in gene therapy and oncolytic virus therapyMartine L M Lamfers, Akseli Hemminki
Handbook of Clinical Neurology|November 8, 2017
Cerebrospinal fluid biomarkers of malignancies located in the central nervous systemCassandra Verheul, Anne Kleijn, Martine L M Lamfers
Cancers|February 15, 2022
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase InhibitorsFederica Fabro, Martine L M Lamfers, Sieger Leenstra
Viruses|August 28, 2021
The Multifaceted Role of Macrophages in Oncolytic VirotherapyLaura Hofman, Sean E Lawler, Martine L M Lamfers
Cancers|February 9, 2021
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for ResponseEftychia Stavrakaki, Clemens M F Dirven, Martine L M Lamfers
Cell Death & Disease|October 7, 2025
Cut the fat: targeting cholesterol and lipid metabolism in glioblastomaSafet Zekanovic, Puspha Achaiber Sing, Sieger Leenstra, et al.
CNS Oncology|March 18, 2016
Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastomaSubramanian Venkatesan, Martine L M Lamfers, Clemens M F Dirven, et al.
Cancers|August 12, 2022
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Sieger Leenstra, et al.
Human Gene Therapy|August 22, 2014
Changing faces in virology: the dutch shift from oncogenic to oncolytic virusesZineb Belcaid, Martine L M Lamfers, Victor W van Beusechem, et al.
Current Cancer Drug Targets|August 17, 2016
Malignant Glioma In Vitro Models: On the Utilization of Stem-like CellsRutger K Balvers, Clemens M F Dirven, Sieger Leenstra, et al.
Pageof 7